TBL1Y and pancreatic neoplasm: Given the tight association between PDAC and metabolic dysfunction (Giovannucci & Michaud, 2007), we thus tested the hypothesis that the TBL1 transcriptional complex may represent an integrator of proliferative and metabolic pathways in pancreatic cancer.